A drug used alone or with other drugs to treat multiple myeloma that has gotten worse or come back after treatment with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Carfilzomib blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called Kyprolis.
Last updated: 2016-01-06
Source: The National Cancer Institute's Dictionary of Cancer Terms (http://www.cancer.gov/dictionary)